Evidence map›Paper›PMID 31040285›Full record

ArticleNature communications2019

Red-shifting mutation of light-driven sodium-pump rhodopsin.

Keiichi Inoue, María Del Carmen Marín, Sahoko Tomida, Ryoko Nakamura, Yuta Nakajima, Massimo Olivucci, Hideki Kandori

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Blue-shifted ancyromonad channelrhodopsins for multiplex optogenetics.bioRxiv : the preprint server for biology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Protonation of Asp116 and distortion of the all-trans retinal chromophore in Krokinobacter eikastus rhodopsin 2 causes a redshift in absorption maximum upon dehydration.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2023
    Article
  12. Diversity of rhodopsin cyclases in zoospore-forming fungi.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  13. NaMolecules (Basel, Switzerland) · 2023
    Review
  14. Article
  15. Evolution of the Automatic Rhodopsin Modeling (ARM) Protocol.Topics in current chemistry (Cham) · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Crystal structure of schizorhodopsin reveals mechanism of inward proton pumping.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 4 countries.

Keiichi InoueDepartment of Life Science and Applied Chemistry, Nagoya Institute of Technology, Showa-ku, Nagoya, 466-8555, Japan.ORCID http://orcid.org/0000-0002-6898-4347
María Del Carmen MarínDipartimento di Biotecnologie, Chimica e Farmacia, Università di Siena, Via A. Moro 2, I-53100, Siena, Italy.ORCID https://orcid.org/0000-0001-5075-8619
Sahoko TomidaDepartment of Life Science and Applied Chemistry, Nagoya Institute of Technology, Showa-ku, Nagoya, 466-8555, Japan.
Ryoko NakamuraDepartment of Life Science and Applied Chemistry, Nagoya Institute of Technology, Showa-ku, Nagoya, 466-8555, Japan.
Yuta NakajimaDepartment of Life Science and Applied Chemistry, Nagoya Institute of Technology, Showa-ku, Nagoya, 466-8555, Japan.
Massimo OlivucciDipartimento di Biotecnologie, Chimica e Farmacia, Università di Siena, Via A. Moro 2, I-53100, Siena, Italy.ORCID http://orcid.org/0000-0002-8247-209X
Hideki KandoriDepartment of Life Science and Applied Chemistry, Nagoya Institute of Technology, Showa-ku, Nagoya, 466-8555, Japan. kandori@nitech.ac.jp.ORCID http://orcid.org/0000-0002-4922-1344
Nagoya Institute of Technology · JPUniversity of Siena · IT

Funding

Computational Design of Highly Fluorescent RhodopsinsR15GM126627 · NIGMS · BOWLING GREEN STATE UNIVERSITY · PI OLIVUCCI, MASSIMO · 2018 to 2018
$337k
MEXT | JST | Science and Technology Research Partnership for Sustainable Development (SATREPS) 15H02391National Science Foundation CHE-CLP-1710191NIGMS NIH HHS GM126627 01NIGMS NIH HHS R15 GM126627
6 · The paper itself

Abstract

Microbial rhodopsins are photoreceptive membrane proteins that transport various ions using light energy. While they are widely used in optogenetics to optically control neuronal activity, rhodopsins that function with longer-wavelength light are highly demanded because of their low phototoxicity and high tissue penetration. Here, we achieve a 40-nm red-shift in the absorption wavelength of a sodium-pump rhodopsin (KR2) by altering dipole moment of residues around the retinal chromophore (KR2 P219T/S254A) without impairing its ion-transport activity. Structural differences in the chromophore of the red-shifted protein from that of the wildtype are observed by Fourier transform infrared spectroscopy. QM/MM models generated with an automated protocol show that the changes in the electrostatic interaction between protein and chromophore induced by the amino-acid replacements, lowered the energy gap between the ground and the first electronically excited state. Based on these insights, a natural sodium pump with red-shifted absorption is identified from Jannaschia seosinensis.

Indexed as

LightChlamydomonasHumansMutationQuantum TheoryRhodopsinSodium-Potassium-Exchanging ATPaseSpectroscopy, Fourier Transform InfraredStatic ElectricityRhodopsinSodium-Potassium-Exchanging ATPase

Identifiers

PMID31040285
PMCPMC6491443
OpenAlexW2943692298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.